Cargando…
Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential
Viral macrodomains possess the ability to counteract host ADP-ribosylation, a post-translational modification implicated in the creation of an antiviral environment via immune response regulation. This brought them into focus as promising therapeutic targets, albeit the close homology to some of the...
Autores principales: | Rack, Johannes Gregor Matthias, Zorzini, Valentina, Zhu, Zihan, Schuller, Marion, Ahel, Dragana, Ahel, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729036/ https://www.ncbi.nlm.nih.gov/pubmed/33202171 http://dx.doi.org/10.1098/rsob.200237 |
Ejemplares similares
-
Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis
por: Fehr, Anthony R., et al.
Publicado: (2018) -
Streptomyces coelicolor macrodomain hydrolase SCO6735 cleaves thymidine-linked ADP-ribosylation of DNA
por: Hloušek-Kasun, Andrea, et al.
Publicado: (2022) -
(ADP-ribosyl)hydrolases: structure, function, and biology
por: Rack, Johannes Gregor Matthias, et al.
Publicado: (2020) -
Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors
por: Schuller, Marion, et al.
Publicado: (2023) -
Disruption of Macrodomain Protein SCO6735 Increases Antibiotic Production in Streptomyces coelicolor
por: Lalić, Jasna, et al.
Publicado: (2016)